Back |
home / stock / tern / tern message board
Subject | By | Source | When |
---|---|---|---|
I thought even the pink sheets require reporting | followinsnsr | investorshub | 07/27/2006 11:15:18 PM |
TERN'S CHART. | SEBASS | investorshub | 06/24/2006 12:53:12 AM |
06/22/06 TERAYON CEO interview at EXPO showing products. | SEBASS | investorshub | 06/24/2006 12:50:34 AM |
Thanks SEBASS. | ScovilleUnits | investorshub | 06/21/2006 1:09:13 PM |
Terayon's inside pictures of Building, CEO, Employees and | SEBASS | investorshub | 06/21/2006 4:25:41 AM |
When are the Charts going to be updated? | ScovilleUnits | investorshub | 06/15/2006 1:12:46 AM |
At least the Bosses get to keep their | ScovilleUnits | investorshub | 05/27/2006 2:03:22 PM |
Will Alcatel-Lucent Seek Foothold in Cable Next? | SEBASS | investorshub | 05/03/2006 3:59:33 AM |
Picking your Spots - CEDMAGAZINE | SEBASS | investorshub | 05/03/2006 3:58:25 AM |
Glow beetle Haaa Haaaa the stock went up | followinsnsr | investorshub | 04/04/2006 8:33:40 PM |
I saw that too. | ScovilleUnits | investorshub | 04/04/2006 1:50:13 AM |
Terayon Communication Systems Receives Delisting Notice from NASDAQ | SEBASS | investorshub | 04/04/2006 1:38:48 AM |
News, Short Squeeze, Breakout and More Instantly...
Terns Pharmaceuticals Inc. Company Name:
TERN Stock Symbol:
NASDAQ Market:
Terns Pharmaceuticals Inc. Website:
2024-07-20 09:30:00 ET Eli Lilly and Novo Nordisk are, for now, the undisputed champions of the market for weight-loss medicines. Thanks to the outrageous popularity of Lilly's drug Zepbound and Novo's product Wegovy, the biggest contest of the moment will go to whoever can ramp up ...
2024-07-17 00:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
FOSTER CITY, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including o...